Company / Shareholders' Equity
CHAMPIONS ONCOLOGY, INC. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$3.8M
FY2025
5-year range
-$1.9M / $9.1M
FY2021-FY2025
Trend
+298.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +298% YoY in FY2025, a notable deviation from the 9-year average annual change of +88%.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -5.9%.
Declined from $9M to $4M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -20.2%
- 5-Year CAGR
- -5.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -5.9%, indicating a declining trend.
- In FY2025, shareholders' equity increased 298.2% year-over-year.
- Peak shareholders' equity was recorded in FY2023.
- Lowest shareholders' equity in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.8M | +298.2% |
| FY2024 | -$1.9M | -120.9% |
| FY2023 | $9.1M | +22.5% |
| FY2022 | $7.4M | +45.7% |
| FY2021 | $5.1M | +0.0% |
| FY2020 | $5.1M | +138.6% |
| FY2019 | $2.1M | +434.3% |
| FY2018 | $400.0K | +68.1% |
| FY2017 | $238.0K | -97.0% |
| FY2016 | $8.1M | +152.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026